• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Repligen Corp (NQ: RGEN )

    148.59 +9.08 (+6.51%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Repligen Corp

    < Previous 1 2 3 4 5 6 Next >
    Recap: Repligen Q1 Earnings
    Repligen (NASDAQ:RGEN) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Repligen Earnings Conference Call Is Coming Up, Here's What You Need To Know
    Repligen (NASDAQ:RGEN) will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q1 2022 earnings results. How to Attend Repligen (RGEN) Conference Call Follow this link to access the... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was... 
    Via Benzinga
    Repligen's Q4 Earnings Beat Expectations, Issues Solid FY22 Guidance
    Repligen Corp (NASDAQ: RGEN)  
    Via Benzinga
    Earnings Scheduled For April 27, 2022
    Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low. 
    Via Benzinga
    Earnings Scheduled For February 17, 2022
    Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
    Via Benzinga
    Elephant Tracking: How to Spot the Market’s Next Mega Winners BEFORE They Take Off
    If you follow an elephant's tracks, you find an elephant. If you follow a large money manager, you'll find the winners they've identified. 
    Via InvestorPlace
    Repligen Earnings Perspective: Return On Capital Employed
    Pulled from Benzinga Pro data, Repligen (NASDAQ:RGEN) showed a loss in earnings since Q3, totaling $29.11 million. Sales, on the other hand, increased by 4.66% to $186.52 million during Q4. 
    Via Benzinga
    10 Biggest Price Target Changes For Friday
    Needham lowered Fiverr International Ltd. (NYSE: FVRR) price target from $205 to $100. Fiverr International shares gained 2% to $80.00 in pre-market trading. Wedbush cut the... 
    Via Benzinga
    The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... 
    Via Benzinga
    Earnings Scheduled For October 28, 2021
    Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •... 
    Via Benzinga
    The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
    Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
    Via Benzinga
    This Foreboding Sign Looms Over Repligen's Chart
    If history is any guide, there may be trouble ahead for shares of Repligen (NASDAQ:RGEN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
    Via Benzinga
    Repligen Stock Shows Leadership With 86 RS Rating
    A RS Rating upgrade for Repligen stock shows improving technical performance for the top-ranked firm in the Medical Products group. 
    Via Investor's Business Daily
    Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript
    RGEN earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In... 
    Via Benzinga
    3 Unstoppable Healthcare Stocks to Buy With Just $1,000
    It doesn't take much when you buy great companies and let them grow. 
    Via The Motley Fool
    10 Biggest Price Target Changes For Friday
    UBS cut FedEx Corporation (NYSE:FDX) price target fr... 
    Via Benzinga
    The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
    Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength... 
    Via Benzinga
    Exposures Product Safety
    Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal
    Repligen Corporation (NASDAQ: RGEN) has agreed to acquire privately-held Avitide Inc for approximately $150 million in cash and stock. The deal consideration includes $75 million... 
    Via Benzinga
    Chief Executive Officer Of Repligen Trades $8.18 Million In Company Stock
    Anthony Hunt, Chief Executive Officer at Repligen (NASDAQ:RGEN), made a large buy and sell of company shares on September 9, according to a new SEC filing. What Happened: A Form 4... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021
    Upgrades According to Roth Capital, the prior rating for Ring Energy Inc (AMEX: 
    Via Benzinga
    The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... 
    Via Benzinga
    The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... 
    Via Benzinga
    Exposures COVID-19
    The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... 
    Via Benzinga
    The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
    Via Benzinga
    The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
    Via Benzinga
    Exposures Product Safety
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.